{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:37:54Z","timestamp":1794710274698,"version":"4.9.1"},"reference-count":325,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.1210\/er.2012-1043","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T13:26:01Z","timestamp":1360243561000},"page":"130-162","source":"Crossref","is-referenced-by-count":442,"title":["Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer"],"prefix":"10.1210","volume":"34","author":[{"given":"J. Julie","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Reproductive Biology Research, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurita","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar E.","family":"Bulun","sequence":"additional","affiliation":[{"name":"Division of Reproductive Biology Research, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2013,1,9]]},"reference":[{"key":"2019041121354751900_B1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsbmb.2006.09.006","article-title":"Molecular mechanisms involved in progesterone receptor regulation of uterine function","volume":"102","author":"Lee","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B2","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"key":"2019041121354751900_B3","first-page":"502","article-title":"Physiological action of progesterone in target tissues","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121354751900_B4","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.1073\/pnas.1732707100","article-title":"Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform","volume":"100","author":"Mulac-Jericevic","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1126\/science.289.5485.1751","article-title":"Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform","volume":"289","author":"Mulac-Jericevic","year":"2000","journal-title":"Science"},{"key":"2019041121354751900_B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B7","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"2019041121354751900_B8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1126\/science.1130471","article-title":"Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist","volume":"314","author":"Poole","year":"2006","journal-title":"Science"},{"key":"2019041121354751900_B9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"2019041121354751900_B11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2019041121354751900_B12","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.1073\/pnas.1013226107","article-title":"Uterine epithelial estrogen receptor \u03b1 is dispensable for proliferation but essential for complete biological and biochemical responses","volume":"107","author":"Winuthayanon","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B13","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1210\/endo.139.11.6317","article-title":"Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis","volume":"139","author":"Kurita","year":"1998","journal-title":"Endocrinology"},{"key":"2019041121354751900_B14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.1197454","article-title":"The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2","volume":"331","author":"Li","year":"2011","journal-title":"Science"},{"key":"2019041121354751900_B15","volume-title":"Anatomy and histology of the uterine corpus","author":"Ferenczy","year":"1987","edition":"3rd ed"},{"key":"2019041121354751900_B16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"2019041121354751900_B17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1242\/jcs.00247","article-title":"The nuclear receptor superfamily","volume":"116","author":"Robinson-Rechavi","year":"2003","journal-title":"J Cell Sci"},{"key":"2019041121354751900_B18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(89)90237-7","article-title":"Gene regulation by steroid hormones","volume":"56","author":"Beato","year":"1989","journal-title":"Cell"},{"key":"2019041121354751900_B19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0092-8674(90)90740-6","article-title":"The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex","volume":"60","author":"Klein-Hitpass","year":"1990","journal-title":"Cell"},{"key":"2019041121354751900_B20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.bi.63.070194.002315","article-title":"Molecular mechanisms of action of steroid\/thyroid receptor superfamily members","volume":"63","author":"Tsai","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"2019041121354751900_B21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/153537020222701104","article-title":"Mechanism of action of progesterone antagonists","volume":"227","author":"Leonhardt","year":"2002","journal-title":"Exp Biol Med (Maywood)"},{"key":"2019041121354751900_B22","first-page":"321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041121354751900_B23","first-page":"1244","article-title":"Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function","volume":"7","author":"Vegeto","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B24","first-page":"1256","article-title":"Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors","volume":"7","author":"Tung","year":"1993","journal-title":"Mol Endocrinol [Erratum (1993) 7:1378]"},{"key":"2019041121354751900_B25","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1016\/S0021-9258(17)32664-9","article-title":"RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism","volume":"269","author":"McDonnell","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041121354751900_B26","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1074\/jbc.M110090200","article-title":"Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells","volume":"277","author":"Richer","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041121354751900_B27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.ge.25.120191.000513","article-title":"Transcription activation by estrogen and progesterone receptors","volume":"25","author":"Gronemeyer","year":"1991","journal-title":"Annu Rev Genet"},{"key":"2019041121354751900_B28","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1074\/jbc.271.11.6217","article-title":"Negative interaction between the RelA(p65) subunit of NF-\u03baB and the progesterone receptor","volume":"271","author":"Kalkhoven","year":"1996","journal-title":"J Biol Chem"},{"key":"2019041121354751900_B29","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.93.12.6169","article-title":"Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells","volume":"93","author":"Bamberger","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1095\/biolreprod.105.043182","article-title":"Role of FOXO1A in the regulation of insulin-like growth factor-binding protein-1 in human endometrial cells: interaction with progesterone receptor","volume":"73","author":"Kim","year":"2005","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B31","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/me.2007-0058","article-title":"Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells","volume":"21","author":"Takano","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J"},{"key":"2019041121354751900_B33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol Cell"},{"key":"2019041121354751900_B34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0092-8674(89)90918-5","article-title":"Steroid hormone receptors compete for factors that mediate their enhancer function","volume":"57","author":"Meyer","year":"1989","journal-title":"Cell"},{"key":"2019041121354751900_B35","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.1016\/S0021-9258(19)50100-4","article-title":"A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms","volume":"267","author":"Meyer","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041121354751900_B36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1210\/endo-112-4-1267","article-title":"The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling","volume":"112","author":"Lessey","year":"1983","journal-title":"Endocrinology"},{"key":"2019041121354751900_B37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J"},{"key":"2019041121354751900_B38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0960-0760(91)90192-8","article-title":"Progestin receptors: isoforms and antihormone action","volume":"40","author":"Gronemeyer","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0960-0760(94)90190-2","article-title":"The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity","volume":"48","author":"McDonnell","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1009503029176","article-title":"The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors","volume":"5","author":"Edwards","year":"2000","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041121354751900_B41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1210\/mend.13.6.0300","article-title":"Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo","volume":"13","author":"Tetel","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B42","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/me.2006-0105","article-title":"Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B","volume":"20","author":"Tung","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/me.2005-0242","article-title":"Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-\u03baB may contribute to the onset of labor through inhibition of PR function","volume":"20","author":"Condon","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B44","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"2019041121354751900_B45","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1210\/endo.139.4.5944","article-title":"The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation","volume":"139","author":"Gass","year":"1998","journal-title":"Endocrinology"},{"key":"2019041121354751900_B46","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/me.2010-0289","article-title":"Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer","volume":"24","author":"Kobayashi","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (mifepristone): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu Rev Med"},{"key":"2019041121354751900_B48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.steroids.2003.08.007","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz","year":"2003","journal-title":"Steroids"},{"key":"2019041121354751900_B49","first-page":"141","article-title":"Role of co-activators and co-repressors in the mechanism of steroid\/thyroid receptor action","volume":"52","author":"Shibata","year":"1997","journal-title":"Recent Prog Horm Res"},{"key":"2019041121354751900_B50","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1073\/pnas.94.15.7879","article-title":"Steroid receptor induction of gene transcription: a two-step model","volume":"94","author":"Jenster","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B51","doi-asserted-by":"crossref","first-page":"12426","DOI":"10.1073\/pnas.231474798","article-title":"Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B52","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1016\/S0021-9258(18)98344-4","article-title":"Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP","volume":"268","author":"Sartorius","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041121354751900_B53","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2006-0524","article-title":"A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator","volume":"21","author":"Madauss","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B54","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/1071557600007001S08","article-title":"Novel mechanisms of progesterone antagonists and progesterone receptor","volume":"7","author":"Edwards","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"2019041121354751900_B55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1210\/me.2006-0274","article-title":"R5020 and RU486 act as progesterone receptor agonists to enhance Sp1\/Sp4-dependent gene transcription by an indirect mechanism","volume":"21","author":"Shatnawi","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0039-128X(00)00178-1","article-title":"Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity","volume":"65","author":"Elger","year":"2000","journal-title":"Steroids"},{"key":"2019041121354751900_B57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2019041121354751900_B58","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-09-2612","article-title":"Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells","volume":"70","author":"Yin","year":"2010","journal-title":"Cancer Res"},{"key":"2019041121354751900_B59","doi-asserted-by":"crossref","first-page":"e29021","DOI":"10.1371\/journal.pone.0029021","article-title":"Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells","volume":"7","author":"Yin","year":"2012","journal-title":"PloS One"},{"key":"2019041121354751900_B60","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1210\/me.2011-1355","article-title":"Research resource: genome-wide profiling of progesterone receptor binding in the mouse uterus","volume":"26","author":"Rubel","year":"2012","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B61","first-page":"141","article-title":"In vitro analysis of the hormonal basis for the sexual dimorphism in the embryonic development of the mouse mammary gland","volume":"25","author":"Kratochwil","year":"1971","journal-title":"J Embryol Exp Morphol"},{"key":"2019041121354751900_B62","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1073\/pnas.73.11.4041","article-title":"Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone","volume":"73","author":"Kratochwil","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jez.1402050203","article-title":"The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice","volume":"205","author":"Cunha","year":"1978","journal-title":"J Exp Zool"},{"key":"2019041121354751900_B64","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1073\/pnas.94.12.6535","article-title":"Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium","volume":"94","author":"Cooke","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B65","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1210\/en.2011-0223","article-title":"Mouse primary uterine cell coculture system revisited: ovarian hormones mimic the aspects of in vivo uterine cell proliferation","volume":"152","author":"Chung","year":"2011","journal-title":"Endocrinology"},{"key":"2019041121354751900_B66","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.cdd.4400797","article-title":"Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system","volume":"8","author":"Kurita","year":"2001","journal-title":"Cell Death Differ"},{"key":"2019041121354751900_B67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1095\/biolreprod62.4.831","article-title":"Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus","volume":"62","author":"Kurita","year":"2000","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B68","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.11-193334","article-title":"Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function","volume":"26","author":"Franco","year":"2012","journal-title":"FASEB J"},{"key":"2019041121354751900_B69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-0436.2005.00033.x","article-title":"The activation function-1 domain of estrogen receptor \u03b1 in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen","volume":"73","author":"Kurita","year":"2005","journal-title":"Differentiation"},{"key":"2019041121354751900_B70","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1095\/biolreprod64.3.831","article-title":"Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium","volume":"64","author":"Pierro","year":"2001","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/humrep\/deh722","article-title":"A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate","volume":"20","author":"Bl\u00e4uer","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semdp.2010.09.002","article-title":"Endometrial hyperplasia","volume":"27","author":"Mills","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"2019041121354751900_B73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"2019041121354751900_B75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ssu.2980060608","article-title":"Recent advances in endometrial cancer","volume":"6","author":"Creasman","year":"1990","journal-title":"Semin Surg Oncol"},{"key":"2019041121354751900_B76","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2019041121354751900_B77","first-page":"S1\u2013140","article-title":"Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment","volume":"24","author":"Creasman","year":"1997","journal-title":"Semin Oncol"},{"key":"2019041121354751900_B78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7819-2-24","article-title":"Cancer of the endometrium: current aspects of diagnostics and treatment","volume":"2","author":"M\u00fcnstedt","year":"2004","journal-title":"World J Surg Oncol"},{"key":"2019041121354751900_B79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"2019041121354751900_B80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","article-title":"The dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk","volume":"57","author":"Key","year":"1988","journal-title":"Br J Cancer"},{"key":"2019041121354751900_B81","first-page":"4360","article-title":"Steroid hormones and endometrial cancer","volume":"38","author":"Siiteri","year":"1978","journal-title":"Cancer Res"},{"key":"2019041121354751900_B82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0027-5107(99)00012-3","article-title":"Estrogen, DNA damage and mutations","volume":"424","author":"Roy","year":"1999","journal-title":"Mutat Res"},{"key":"2019041121354751900_B83","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1055-9965.EPI-11-0119","article-title":"Polymorphisms in nucleotide excision repair genes and endometrial cancer risk","volume":"20","author":"Doherty","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041121354751900_B84","first-page":"4374","article-title":"Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients","volume":"56","author":"Hemminki","year":"1996","journal-title":"Cancer Res"},{"key":"2019041121354751900_B85","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/21.8.1461","article-title":"Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen","volume":"21","author":"Shibutani","year":"2000","journal-title":"Carcinogenesis"},{"key":"2019041121354751900_B86","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM196102022640503","article-title":"Progestational agents in the treatment of carcinoma of the endometrium","volume":"264","author":"Kelley","year":"1961","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B87","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/1097-0142(196512)18:12<1563::AID-CNCR2820181208>3.0.CO;2-P","article-title":"Use of progestational agents in the management of endometrial cancer","volume":"18","author":"Kistner","year":"1965","journal-title":"Cancer"},{"key":"2019041121354751900_B88","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"key":"2019041121354751900_B89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B90","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B91","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"2019041121354751900_B92","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-011-1959-x","article-title":"Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium","volume":"285","author":"Park","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"2019041121354751900_B93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/IGC.0b013e31820003de","article-title":"Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved","volume":"21","author":"Perri","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"key":"2019041121354751900_B95","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1525-1438.2007.00897.x","article-title":"Hormone therapy in advanced and recurrent endometrial cancer: a systematic review","volume":"17","author":"Decruze","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B96","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019041121354751900_B97","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/1055-9965.EPI-07-0551","article-title":"Progestin treatment induces apoptosis and modulates transforming growth factor-\u03b2 in the uterine endometrium","volume":"17","author":"Rodriguez","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041121354751900_B98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2003.09.018","article-title":"Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Whitney","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B99","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/gyno.1998.5087","article-title":"Steroid receptor expression in endometria from women treated with tamoxifen","volume":"70","author":"Kommoss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B100","first-page":"CD007926","article-title":"Hormonal therapy in advanced or recurrent endometrial cancer","volume":"12","author":"Kokka","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121354751900_B101","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/IGC.0b013e3181ef6d87","article-title":"Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports","volume":"20","author":"Garavaglia","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B102","doi-asserted-by":"crossref","first-page":"353679","DOI":"10.1155\/2010\/353679","article-title":"Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist","volume":"2010","author":"Dupont","year":"2010","journal-title":"Sarcoma"},{"key":"2019041121354751900_B103","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2009.02.005","article-title":"The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study","volume":"144","author":"Dahhan","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121354751900_B104","first-page":"2869","article-title":"Low-grade endometrial stromal sarcoma of the uterus: review of 10 cases","volume":"28","author":"Landr\u00e9at","year":"2008","journal-title":"Anticancer Res"},{"key":"2019041121354751900_B105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2011.10.010","article-title":"Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment","volume":"125","author":"Beck","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2010.12.360","article-title":"Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy","volume":"121","author":"Cheng","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004347-199907000-00008","article-title":"Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis","volume":"18","author":"Demopoulos","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"2019041121354751900_B108","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2019041121354751900_B109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer","volume":"28","author":"Kim","year":"2010","journal-title":"Semin Reprod Med"},{"key":"2019041121354751900_B110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121354751900_B111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1877-1173(09)87002-6","article-title":"Progesterone receptor action in leiomyoma and endometrial cancer","volume":"87","author":"Kim","year":"2009","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2019041121354751900_B112","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2019041121354751900_B113","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1525-1438.2007.01166.x","article-title":"Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci\u2014review of more than 25 biopsies from five patients","volume":"18","author":"Kamoi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B114","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9378(88)90075-0","article-title":"Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium","volume":"158","author":"Ehrlich","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B115","first-page":"881","article-title":"Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors","volume":"62","author":"Dai","year":"2002","journal-title":"Cancer Res"},{"key":"2019041121354751900_B116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1349-7006.1996.tb00255.x","article-title":"Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro","volume":"87","author":"Ueda","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"2019041121354751900_B117","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12672-011-0065-7","article-title":"Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1\u201359-mediated apoptosis","volume":"2","author":"Neubauer","year":"2011","journal-title":"Horm Cancer"},{"key":"2019041121354751900_B118","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/en.2007-0756","article-title":"The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma","volume":"149","author":"Ward","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121354751900_B119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-8258(03)00089-1","article-title":"Progestin suppresses matrix metalloproteinase production in endometrial cancer","volume":"89","author":"Di Nezza","year":"2003","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/JME-06-0030","article-title":"Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression","volume":"38","author":"Jaffe","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"2019041121354751900_B121","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1078-0432.CCR-10-1287","article-title":"Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth","volume":"17","author":"Kyo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2019041121354751900_B122","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/molehr\/4.9.899","article-title":"Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone","volume":"4","author":"Shiozawa","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"2019041121354751900_B123","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1210\/en.2005-0359","article-title":"Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin","volume":"146","author":"Uchida","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121354751900_B124","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/en.2006-0896","article-title":"Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin","volume":"148","author":"Uchida","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121354751900_B125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/ijgc-00009577-200602001-00086","article-title":"Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma","volume":"16","author":"Watanabe","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B126","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1067\/mob.2001.113844","article-title":"Molecular tools to reestablish progestin control of endometrial cancer cell proliferation","volume":"184","author":"Dai","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.steroids.2007.09.010","article-title":"Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone","volume":"73","author":"Paulssen","year":"2008","journal-title":"Steroids"},{"key":"2019041121354751900_B128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1525-1438.2006.00279.x","article-title":"Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells","volume":"16","author":"Gielen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"2019041121354751900_B129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/107155760301000110","article-title":"Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines","volume":"10","author":"Smid-Koopman","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"2019041121354751900_B130","first-page":"1053","article-title":"High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis","volume":"29","author":"Moe","year":"2009","journal-title":"Anticancer Res"},{"key":"2019041121354751900_B131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsbmb.2008.12.003","article-title":"Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa)","volume":"113","author":"\u00d8rbo","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B132","first-page":"112","article-title":"Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor","volume":"131","author":"Press","year":"1988","journal-title":"Am J Pathol"},{"key":"2019041121354751900_B133","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/jrf.0.0940363","article-title":"Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause","volume":"94","author":"Snijders","year":"1992","journal-title":"J Reprod Fertil"},{"key":"2019041121354751900_B134","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2007-991042","article-title":"Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives","volume":"25","author":"Gellersen","year":"2007","journal-title":"Semin Reprod Med"},{"key":"2019041121354751900_B135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/carcin\/20.2.339","article-title":"Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium","volume":"20","author":"Carmichael","year":"1999","journal-title":"Carcinogenesis"},{"key":"2019041121354751900_B136","first-page":"4402","article-title":"Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen","volume":"63","author":"Shibutani","year":"2003","journal-title":"Cancer Res"},{"key":"2019041121354751900_B137","first-page":"2093","article-title":"Stromal PRs mediate induction of 17\u03b2-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2","volume":"15","author":"Yang","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B138","first-page":"79","article-title":"Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells","volume":"62","author":"Arnold","year":"2002","journal-title":"Cancer Res"},{"key":"2019041121354751900_B139","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ygyno.2011.07.004","article-title":"Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K\/AKt\/survivin pathway in endometrial adenocarcinoma cells in vitro","volume":"123","author":"Shi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2019041121354751900_B140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yexmp.2011.01.006","article-title":"Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures","volume":"90","author":"Sampey","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"2019041121354751900_B141","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1158\/0008-5472.CAN-10-3166","article-title":"Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer","volume":"71","author":"Tanwar","year":"2011","journal-title":"Cancer Res"},{"key":"2019041121354751900_B142","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"2019041121354751900_B143","first-page":"448","article-title":"Pregnancy success following surgical correction of imperforate hymen and complete transverse vaginal septum","volume":"59","author":"Rock","year":"1982","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B144","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.fertnstert.2004.04.065","article-title":"In utero exposures and the incidence of endometriosis","volume":"82","author":"Missmer","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0301-2115(98)00213-9","article-title":"The genetics of endometriosis","volume":"82","author":"Kennedy","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121354751900_B146","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/humrep\/deh147","article-title":"The endometriosis syndromes: a clinical classification in the presence of aetiological confusion and therapeutic anarchy","volume":"19","author":"Garry","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B147","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/humrep\/deh287","article-title":"Endometriosis rediscovered?","volume":"19","author":"Brosens","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B148","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0015-0282(97)81392-1","article-title":"Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis","volume":"67","author":"Guzick","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B149","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(97)81468-9","article-title":"Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain","volume":"68","author":"Stovall","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B150","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199306173282407","article-title":"Endometriosis","volume":"328","author":"Olive","year":"1993","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B151","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJM200107263450407","article-title":"Treatment of endometriosis","volume":"345","author":"Olive","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B152","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.AOG.0000142714.54857.f8","article-title":"Reproductive history and endometriosis among premenopausal women","volume":"104","author":"Missmer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B153","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.fertnstert.2005.09.064","article-title":"Aromatase inhibitors: the next generation of therapeutics for endometriosis?","volume":"85","author":"Attar","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00001703-199406000-00012","article-title":"RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri","volume":"6","author":"Murphy","year":"1994","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121354751900_B156","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/molehr\/5.7.651","article-title":"Oestrogen receptor (ER)-\u03b1 and ER-\u03b2 isoforms in normal endometrial and endometriosis-derived stromal cells","volume":"5","author":"Brandenberger","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"2019041121354751900_B157","first-page":"2897","article-title":"Progesterone receptor isoform A but not B is expressed in endometriosis","volume":"85","author":"Attia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B158","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1095\/biolreprod.107.061804","article-title":"Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis","volume":"77","author":"Xue","year":"2007","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B159","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","article-title":"Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment","volume":"57","author":"Bulun","year":"2005","journal-title":"Pharmacol Rev"},{"key":"2019041121354751900_B160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","article-title":"Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B161","first-page":"1118","article-title":"Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis","volume":"81","author":"Tseng","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B162","first-page":"174","article-title":"Aromatase expression in endometriosis","volume":"81","author":"Noble","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B163","first-page":"600","article-title":"Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells","volume":"82","author":"Noble","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B164","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1210\/en.2006-1692","article-title":"Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","volume":"148","author":"Burney","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121354751900_B165","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/en.2003-0043","article-title":"Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility","volume":"144","author":"Kao","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121354751900_B166","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb02769.x","article-title":"Angiogenic factors in endometriosis","volume":"955","author":"Taylor","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"2019041121354751900_B168","first-page":"351","article-title":"Endometriosis as an autoimmune disease","volume":"43","author":"Bartosik","year":"1985","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B169","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2008-1068760","article-title":"Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis?","volume":"15","author":"Osteen","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"2019041121354751900_B170","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/humrep\/16.9.1802","article-title":"Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis","volume":"16","author":"Dmowski","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B171","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.fertnstert.2003.11.048","article-title":"Reduction of apoptosis and proliferation in endometriosis","volume":"82","author":"B\u00e9liard","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B172","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00006254-200211000-00023","article-title":"COX-2 inhibitors and their role in gynecology","volume":"57","author":"Hayes","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"2019041121354751900_B173","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B174","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1210\/jc.2007-0494","article-title":"Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5\u2032 CpG island in endometriosis","volume":"92","author":"Xue","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/deq302","article-title":"\u2018Waiting for Godot\u2019: a commonsense approach to the medical treatment of endometriosis","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B176","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)58089-3","article-title":"Endometriosis and pelvic pain: relation to disease stage and localization","volume":"65","author":"Vercellini","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B177","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0015-0282(97)00193-3","article-title":"Progestins for symptomatic endometriosis: a critical analysis of the evidence","volume":"68","author":"Vercellini","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B178","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"2019041121354751900_B179","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1210\/en.2003-0289","article-title":"Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells is mediated by the prostaglandin EP2 receptor","volume":"144","author":"Sun","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121354751900_B180","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/endo.143.6.8885","article-title":"Global gene profiling in human endometrium during the window of implantation","volume":"143","author":"Kao","year":"2002","journal-title":"Endocrinology"},{"key":"2019041121354751900_B181","first-page":"604","article-title":"The physiology and pathology of the female reproductive axis. Williams textbook of endocrinology","author":"Bulun","year":"2011","edition":"12th ed"},{"key":"2019041121354751900_B182","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1210\/endo.140.10.7070","article-title":"Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells","volume":"140","author":"Brosens","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121354751900_B183","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0015-0282(03)00982-8","article-title":"Steroid receptor and aromatase expression in baboon endometriotic lesions","volume":"80","author":"Fazleabas","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B184","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2005.11.041","article-title":"Progesterone resistance in endometriosis: link to failure to metabolize estradiol","volume":"248","author":"Bulun","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121354751900_B185","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B186","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1210\/jc.2011-1527","article-title":"Increased activation of the PI3K\/AKT pathway compromises decidualization of stromal cells from endometriosis","volume":"97","author":"Yin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B187","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2004.11.026","article-title":"Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis","volume":"83","author":"Osteen","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B188","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1172\/JCI117569","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium","volume":"94","author":"Casey","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121354751900_B189","first-page":"1319","article-title":"Human 17\u03b2-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle","volume":"83","author":"Mustonen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B190","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2007-1536","article-title":"Retinoic acid (RA) regulates 17\u03b2-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1\/SP3 for estradiol metabolism","volume":"93","author":"Cheng","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B191","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/endo-94-2-419","article-title":"Estradiol and 20\u03b1-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle","volume":"94","author":"Tseng","year":"1974","journal-title":"Endocrinology"},{"key":"2019041121354751900_B192","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/endo-97-4-825","article-title":"Induction of human endometrial estradiol dehydrogenase by progestins","volume":"97","author":"Tseng","year":"1975","journal-title":"Endocrinology"},{"key":"2019041121354751900_B193","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/endo-111-3-743","article-title":"Distribution of progesterone receptor, estradiol dehydrogenase, and 20\u03b1-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium","volume":"111","author":"Satyaswaroop","year":"1982","journal-title":"Endocrinology"},{"key":"2019041121354751900_B194","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00016348409156981","article-title":"Cytosol estrogen and progestin receptor concentrations and 17 \u03b2-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment","volume":"123","author":"Kauppila","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"2019041121354751900_B195","doi-asserted-by":"crossref","first-page":"391.e1","DOI":"10.1016\/j.ajog.2006.12.014","article-title":"Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17\u03b2-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism","volume":"196","author":"Cheng","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B196","first-page":"4474","article-title":"Deficient 17\u03b2-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17\u03b2-estradiol","volume":"83","author":"Zeitoun","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B197","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1210\/jc.2010-0459","article-title":"Altered retinoid uptake and action contributes to cell survival in endometriosis","volume":"95","author":"Pavone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B198","volume-title":"Goodman and Gilman's: the pharmacological basis of therapeutics","author":"Brunton","year":"2006","edition":"11th ed"},{"key":"2019041121354751900_B199","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","article-title":"A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A","volume":"315","author":"Kawaguchi","year":"2007","journal-title":"Science"},{"key":"2019041121354751900_B200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pharmtox.46.120604.141156","article-title":"Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis","volume":"46","author":"Mark","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2019041121354751900_B201","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"Schug","year":"2007","journal-title":"Cell"},{"key":"2019041121354751900_B202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0079-6603(08)60722-9","article-title":"Retinoic acid: its biosynthesis and metabolism","volume":"63","author":"Napoli","year":"1999","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"2019041121354751900_B203","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3480481","article-title":"Retinoid-binding proteins: mediators of retinoid action","volume":"348","author":"Noy","year":"2000","journal-title":"Biochem J"},{"key":"2019041121354751900_B204","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/der172","article-title":"Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action","volume":"26","author":"Pavone","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B205","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B206","first-page":"8","article-title":"Management of uterine leiomyomata: what do we really know?","volume":"100","author":"Myers","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B207","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B208","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B209","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006250-199404000-00011","article-title":"Hysterectomy in the United States, 1988\u20131990","volume":"83","author":"Wilcox","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B210","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0015-0282(16)58098-4","article-title":"The effects of hormone replacement therapy on uterine fibroids in postmenopausal women","volume":"65","author":"Sener","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B211","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5122(02)00159-7","article-title":"Effect of hormone replacement therapy on uterine fibroids in postmenopausal women\u2014a 3-year study","volume":"43","author":"Yang","year":"2002","journal-title":"Maturitas"},{"key":"2019041121354751900_B212","first-page":"1053","article-title":"Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas","volume":"98","author":"Palomba","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B213","first-page":"911","article-title":"HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm","volume":"150","author":"Williams","year":"1997","journal-title":"Am J Pathol"},{"key":"2019041121354751900_B214","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17-\u03b2 Estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J Cell Physiol"},{"key":"2019041121354751900_B215","first-page":"2192","article-title":"Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma","volume":"83","author":"Shimomura","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B216","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/09513590801893315","article-title":"Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells","volume":"24","author":"Park","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"2019041121354751900_B217","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj1820493","article-title":"Abnormal ribosome assembly in a mutant of Escherichia coli","volume":"182","author":"Butler","year":"1979","journal-title":"Biochem J"},{"key":"2019041121354751900_B218","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/endo.141.10.7719","article-title":"In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine\/intracrine mechanism","volume":"141","author":"Sumitani","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121354751900_B219","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/107155769500200307","article-title":"Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures","volume":"2","author":"Andersen","year":"1995","journal-title":"J Soc Gynecol Investig"},{"key":"2019041121354751900_B220","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/humrep\/den087","article-title":"A low concentration of genistein induces estrogen receptor-\u03b1 and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells","volume":"23","author":"Di","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B221","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B222","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121354751900_B223","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B224","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041121354751900_B226","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B227","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/01926230290105839","article-title":"Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES)","volume":"30","author":"Newbold","year":"2002","journal-title":"Toxicol Pathol"},{"key":"2019041121354751900_B228","first-page":"236","article-title":"Structure and origin of uterine and extragenital fibroids induced experimentally in the guinea pig by prolonged administration of estrogens","volume":"1","author":"Lipschotz","year":"1941","journal-title":"Cancer Res"},{"key":"2019041121354751900_B229","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1006\/bbrc.1994.2324","article-title":"The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (TSC2) gene","volume":"203","author":"Hino","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121354751900_B230","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1073\/pnas.91.24.11413","article-title":"Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene","volume":"91","author":"Yeung","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B231","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0195-70","article-title":"A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer","volume":"9","author":"Kobayashi","year":"1995","journal-title":"Nat Genet"},{"key":"2019041121354751900_B232","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.10281","article-title":"Uterine leiomyoma in the Eker rat: a unique model for important diseases of women","volume":"38","author":"Walker","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"2019041121354751900_B233","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B234","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0015-0282(02)03366-6","article-title":"Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma","volume":"78","author":"Cermik","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(93)90135-6","article-title":"Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas","volume":"169","author":"Brandon","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B236","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B237","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004347-198506000-00001","article-title":"The effect of progestins on the mitotic activity of uterine fibromyomas","volume":"4","author":"Tiltman","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"2019041121354751900_B238","first-page":"1179","article-title":"Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction","volume":"78","author":"Harrison-Woolrych","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B239","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000292738","article-title":"Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"2019041121354751900_B240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(01)00588-7","article-title":"Effect of different doses of progestin on uterine leiomyomas in postmenopausal women","volume":"102","author":"Palomba","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121354751900_B241","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B242","first-page":"1439","article-title":"A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin \u201cadd-back\u201d regimens for women with leiomyomata uteri","volume":"76","author":"Friedman","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B243","first-page":"513","article-title":"Regression of uterine leiomyomata in response to the antiprogesterone RU 486","volume":"76","author":"Murphy","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B244","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B245","first-page":"243","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B246","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1095\/biolreprod32.4.795","article-title":"Selective release of follicle-stimulating hormone and luteinizing hormone by 5\u03b1-dihydroprogesterone and 3\u03b1,5\u03b1- tetrahydroprogesterone in pregnant mare's serum gonadotropin-primed immature rats exposed to constant light","volume":"32","author":"Murphy","year":"1985","journal-title":"Biol Reprod"},{"key":"2019041121354751900_B247","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B248","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systematic review of mifepristone for the treatment of uterine leiomyomata","volume":"103","author":"Steinauer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B249","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"Chwalisz","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmig.2005.01.022","article-title":"Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas","volume":"12","author":"Eisinger","year":"2005","journal-title":"J Minim Invasive Gynecol"},{"key":"2019041121354751900_B251","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2019041121354751900_B252","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","article-title":"Mechanical homeostasis is altered in uterine leiomyoma","volume":"198","author":"Rogers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121354751900_B253","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2353\/ajpath.2009.081110","article-title":"A novel organotypic model mimics the tumor microenvironment","volume":"175","author":"Nurmenniemi","year":"2009","journal-title":"Am J Pathol"},{"key":"2019041121354751900_B254","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/molehr\/gal018","article-title":"In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells","volume":"12","author":"Zaitseva","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"2019041121354751900_B255","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/molehr\/2.11.823","article-title":"Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures","volume":"2","author":"Severino","year":"1996","journal-title":"Mol Hum Reprod"},{"key":"2019041121354751900_B256","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121354751900_B257","first-page":"10","article-title":"Sex steroidal modulation of collagen metabolism in uterine leiomyomas","volume":"36","author":"Ohara","year":"2009","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2019041121354751900_B258","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B259","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0015-0282(00)01660-5","article-title":"Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment","volume":"75","author":"Ito","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B260","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0015-0282(97)00273-2","article-title":"Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment","volume":"68","author":"Kawamura","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121354751900_B261","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004347-199507000-00007","article-title":"Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin","volume":"14","author":"Crow","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"2019041121354751900_B262","first-page":"671","article-title":"Pregnancy-related changes in the size of uterine leiomyomas","volume":"51","author":"Neiger","year":"2006","journal-title":"J Reprod Med"},{"key":"2019041121354751900_B263","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7863\/jum.1992.11.10.511","article-title":"Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study","volume":"11","author":"Rosati","year":"1992","journal-title":"J Ultrasound Med"},{"key":"2019041121354751900_B264","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jmig.2006.04.003","article-title":"Volume change of uterine myomas during pregnancy: do myomas really grow?","volume":"13","author":"Hammoud","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"key":"2019041121354751900_B265","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-0528.1988.tb12807.x","article-title":"Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study","volume":"95","author":"Aharoni","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041121354751900_B266","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121354751900_B267","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"2019041121354751900_B268","doi-asserted-by":"crossref","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","article-title":"Role of stem cells in human uterine leiomyoma growth","volume":"7","author":"Ono","year":"2012","journal-title":"PloS One"},{"key":"2019041121354751900_B269","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","article-title":"Cracking the estrogen receptor's posttranslational code in breast tumors","volume":"32","author":"Le Romancer","year":"2011","journal-title":"Endocr Rev"},{"key":"2019041121354751900_B270","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature09027","article-title":"Control of mammary stem cell function by steroid hormone signalling","volume":"465","author":"Asselin-Labat","year":"2010","journal-title":"Nature"},{"key":"2019041121354751900_B271","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/en.2008-1630","article-title":"DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast","volume":"150","author":"Graham","year":"2009","journal-title":"Endocrinology"},{"key":"2019041121354751900_B272","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"key":"2019041121354751900_B273","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"2019041121354751900_B274","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/humrep\/den228","article-title":"The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology","volume":"23","author":"Engman","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B275","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1210\/me.2002-0169","article-title":"A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development","volume":"16","author":"Ismail","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B276","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0960-0760(01)00182-0","article-title":"Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging","volume":"80","author":"Shyamala","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B277","first-page":"945","article-title":"Progesterone receptors in the mouse mammary duct: distribution and developmental regulation","volume":"7","author":"Silberstein","year":"1996","journal-title":"Cell Growth Diff"},{"key":"2019041121354751900_B278","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.95.9.5076","article-title":"A paracrine role for the epithelial progesterone receptor in mammary gland development","volume":"95","author":"Brisken","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B279","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/bcr40","article-title":"Transforming growth factor-\u03b2 and breast cancer: mammary gland development","volume":"2","author":"Barcellos-Hoff","year":"2000","journal-title":"Breast Cancer Res"},{"key":"2019041121354751900_B280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/bcr1520","article-title":"Stop! In the name of transforming growth factor-\u03b2: keeping estrogen receptor-\u03b1-positive mammary epithelial cells from proliferating","volume":"8","author":"Grimm","year":"2006","journal-title":"Breast Cancer Res"},{"key":"2019041121354751900_B281","first-page":"4987","article-title":"Dissociation between steroid receptor expression and cell proliferation in the human breast","volume":"57","author":"Clarke","year":"1997","journal-title":"Cancer Res"},{"key":"2019041121354751900_B282","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/BD-2003-18102","article-title":"Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression","volume":"18","author":"Rosen","year":"2003","journal-title":"Breast Dis"},{"key":"2019041121354751900_B283","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006186719322","article-title":"Pattern of distribution of cells positive for estrogen receptor \u03b1 and progesterone receptor in relation to proliferating cells in the mammary gland","volume":"53","author":"Russo","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"2019041121354751900_B284","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10911-009-9160-6","article-title":"Hormone-responsive model of primary human breast epithelium","volume":"14","author":"Graham","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041121354751900_B285","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"2019041121354751900_B286","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"2019041121354751900_B287","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1210\/en.2008-0768","article-title":"Transcriptional response of the murine mammary gland to acute progesterone exposure","volume":"149","author":"Fernandez-Valdivia","year":"2008","journal-title":"Endocrinology"},{"key":"2019041121354751900_B288","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.0915148107","article-title":"Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland","volume":"107","author":"Beleut","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121354751900_B289","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1096\/fj.10-157982","article-title":"Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression","volume":"24","author":"Mukherjee","year":"2010","journal-title":"FASEB J"},{"key":"2019041121354751900_B290","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnci\/djj267","article-title":"Steroid hormone receptor status of mouse mammary stem cells","volume":"98","author":"Asselin-Labat","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2019041121354751900_B291","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12015-007-0018-2","article-title":"The emerging picture of the mouse mammary stem cell","volume":"3","author":"Vaillant","year":"2007","journal-title":"Stem Cell Rev"},{"key":"2019041121354751900_B292","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/bcr452","article-title":"The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis","volume":"4","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res"},{"key":"2019041121354751900_B293","first-page":"993","article-title":"Estrogen receptor expression of benign breast epithelium and its association with breast cancer","volume":"54","author":"Khan","year":"1994","journal-title":"Cancer Res"},{"key":"2019041121354751900_B294","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0002-9440(10)65498-3","article-title":"Estrogen receptor-positive proliferating cells in the normal and precancerous breast","volume":"155","author":"Shoker","year":"1999","journal-title":"Am J Pathol"},{"key":"2019041121354751900_B295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(02)00461-5","article-title":"Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro","volume":"188","author":"Chatterton","year":"2002","journal-title":"Cancer Lett"},{"key":"2019041121354751900_B296","first-page":"4276","article-title":"Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function","volume":"59","author":"Lydon","year":"1999","journal-title":"Cancer Res"},{"key":"2019041121354751900_B297","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B298","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/MCB.23.3.1095-1111.2003","article-title":"Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells","volume":"23","author":"Labriola","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2019041121354751900_B299","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.GME.0000155206.53856.41","article-title":"The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells","volume":"12","author":"Kr\u00e4mer","year":"2005","journal-title":"Menopause"},{"key":"2019041121354751900_B300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2005.12.004","article-title":"The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells","volume":"129","author":"Kr\u00e4mer","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121354751900_B301","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humrep\/der378","article-title":"Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro","volume":"27","author":"Cooley","year":"2012","journal-title":"Hum Reprod"},{"key":"2019041121354751900_B302","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B303","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1158\/0008-5472.CAN-11-3290","article-title":"Estrogen receptor \u03b1 mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1\/MYC promoters","volume":"72","author":"Giulianelli","year":"2012","journal-title":"Cancer Res"},{"key":"2019041121354751900_B304","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2011.10.030","article-title":"The biology of progesterone receptor in the normal mammary gland and in breast cancer","volume":"357","author":"Obr","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121354751900_B305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/me.2006-0337","article-title":"The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle","volume":"21","author":"Boonyaratanakornkit","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B306","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/MCB.23.6.1994-2008.2003","article-title":"Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src\/Erk pathway in mammalian cells","volume":"23","author":"Ballar\u00e9","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2019041121354751900_B307","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/me.2007-0437","article-title":"Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors","volume":"22","author":"Faivre","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B308","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/me.2004-0287","article-title":"Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology","volume":"19","author":"Jacobsen","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B309","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1024031731269","article-title":"Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts","volume":"79","author":"Sartorius","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"2019041121354751900_B310","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/me.2007-0443","article-title":"Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms","volume":"22","author":"Hardy","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B311","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1987.296","article-title":"Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies","volume":"56","author":"Nielsen","year":"1987","journal-title":"Br J Cancer"},{"key":"2019041121354751900_B312","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/427787a","article-title":"Cancer without disease","volume":"427","author":"Folkman","year":"2004","journal-title":"Nature"},{"key":"2019041121354751900_B313","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm.2328","article-title":"Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression","volume":"17","author":"Bissell","year":"2011","journal-title":"Nat Med"},{"key":"2019041121354751900_B314","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pathol.1.110304.100224","article-title":"Tumor stroma and regulation of cancer development","volume":"1","author":"Tlsty","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"2019041121354751900_B315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1018738721656","article-title":"The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland","volume":"3","author":"Woodward","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041121354751900_B316","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1018766000275","article-title":"Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse","volume":"3","author":"Fendrick","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2019041121354751900_B317","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tem.2011.10.003","article-title":"Aromatase, breast cancer and obesity: a complex interaction","volume":"23","author":"Bulun","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121354751900_B318","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/endo.143.8.8971","article-title":"Hepatocyte growth factor is required for progestin-induced epithelial cell proliferation and alveolar-like morphogenesis in serum-free culture of normal mammary epithelial cells","volume":"143","author":"Sunil","year":"2002","journal-title":"Endocrinology"},{"key":"2019041121354751900_B319","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/mend.11.6.9891","article-title":"Mammary gland development is mediated by both stromal and epithelial progesterone receptors","volume":"11","author":"Humphreys","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041121354751900_B320","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1645","article-title":"Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models","volume":"9","author":"Rajkumar","year":"2007","journal-title":"Breast Cancer Res"},{"key":"2019041121354751900_B321","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0960-0760(97)00128-3","article-title":"In situ localization of progesterone receptors in normal mouse mammary glands: absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium","volume":"63","author":"Shyamala","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121354751900_B322","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/en.2005-0346","article-title":"Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development","volume":"146","author":"Aupperlee","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121354751900_B323","first-page":"1320","article-title":"Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression","volume":"61","author":"Shekhar","year":"2001","journal-title":"Cancer Res"},{"key":"2019041121354751900_B324","doi-asserted-by":"crossref","first-page":"a003244","DOI":"10.1101\/cshperspect.a003244","article-title":"The role of the microenvironment in mammary gland development and cancer","volume":"2","author":"Polyak","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2019041121354751900_B325","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2353\/ajpath.2009.080658","article-title":"Caveolin-1\u2212\/\u2212 null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts","volume":"174","author":"Sotgia","year":"2009","journal-title":"Am J Pathol"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/34\/1\/130\/8863722\/edrv0130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:39:25Z","timestamp":1688017165000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/34\/1\/130\/2354682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":325,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,9]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2012-1043","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}